Divi's Laboratories (DIVISLAB) — Board Meeting

Divi's Laboratories announced a ₹30 per share dividend for FY 2024-25, payable after August 16, 2025, contingent on shareholder approval at the August 11 AGM, with a record date of July 25, 2025. The company detailed mandatory tax deduction at source (TDS) rules for dividend payments, requiring shareholders to submit forms like Form 15G/H, tax residency certificates, and PAN-Aadhaar linkage details by July 25, 2025, to claim exemptions or lower rates. Non-compliance triggers 20% TDS, and dividend payments will be made electronically post-approval.

📄 View Original Announcement (PDF)

📊 Stock Analysis — DIVISLAB ✨ Ask AI About This

About Divi's Laboratories Limited (DIVISLAB)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,79,470.03 Cr P/E: 72.4 ROE: 16.6% ROCE: 22.1%

View full DIVISLAB stock details →

📡 Get AI alerts when DIVISLAB files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track DIVISLAB — Free

💡 Ask AI about this filing

"How does this board meeting affect Divi's Laboratories Limited's outlook?" "What did Divi's Laboratories Limited announce on 29 May 2025?" "Is this positive or negative for DIVISLAB?"

Ask AI Free →

📊 More DIVISLAB filings

See all DIVISLAB filings →

🔥 Also filed on 29 May 2025

APOLLOHOSP Apollo Hospitals Enterprise Limited Insider Trading SUNPHARMA Sun Pharmaceutical Industries Limited Financial Results SHRIRAMFIN Shriram Finance Limited Corporate Action WIPRO Wipro Limited Corporate Action VEDL Vedanta Limited Corporate Action APOLLOHOSP Apollo Hospitals Enterprise Limited Insider Trading

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when DIVISLAB files new disclosures

Track DIVISLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.